Loading clinical trials...
Loading clinical trials...
Clinical results on intra-arterial adjuvant chemotherapy for prevention of liver metastasis following curative resection of pancreatic cancer
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Peking University Third Hospital
NCT07432633 · Colorectal Cancer, Epithelial Ovarian Cancer, and more
NCT06287723 · Colorectal Cancer, Liver Metastases, and more
NCT07627711 · Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced, and more
NCT07217717 · Pancreatic Ductal Adenocarcinoma (PDAC)
NCT02600949 · Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, and more
Department of General Surgery,Peking University Third Hospital
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions